The latest verified reporting and analysis across technology.
A Delaware jury will hear Qualcomm’s claims that Arm withheld contractually required tools and publicized a termination threat. Arm denies wrongdoing, and the court has not decided whether Qualcomm can suspend royalties for up to five years.
Read story
Novartis will pay $575 million upfront for worldwide rights to ABO2203 and options on other Abogen RNA programs. The much larger headline figure depends on development, approvals and commercialization that may never occur.
Read story
A prospective convertible facility disclosed in Anthropic’s IPO papers shows how AI infrastructure is becoming a financing structure as well as a technology stack. The $42 billion is a ceiling, not money already borrowed or spent.
Read story
A Delaware lawsuit adds JA Solar companies and American Panel Solutions to a growing dispute over a manufacturing patent for high-efficiency crystalline-silicon cells. The filing could test how broadly one of solar's most commercially important process portfolios reaches.
Read story
The multi-year agreement gives Amazon broader access to application-optimized silicon blueprints while shifting Synopsys toward a license-plus-royalty model. It is a major test of how reusable chip IP will shape the custom-silicon race.
Read story
The first U.S. appellate result in an AI-training copyright dispute leaves Ross Intelligence's fair-use defense rejected, but the sealed opinion makes sweeping conclusions premature.
Read story
A Delaware judge refused to dismiss Bayer and Monsanto’s patent suits against Moderna, Pfizer and BioNTech. The ruling keeps the cases alive, but does not establish infringement or finally settle the patent’s validity.
Read story
The court said combining browsing history, page context and revenue-weighted ad selection remained an abstract idea under Section 101. The nonprecedential ruling is a focused warning about claiming business logic without a specific computing improvement.
Read story
A San Diego jury found that Apple infringed two Taction haptics patents and awarded $5.72 billion, but rejected willfulness. The verdict is a major patent result—not the final endpoint of a case Apple says it will appeal.
Read story